Peissenberg, Germany

Carina Kopp

This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Genentech, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carina Kopp. Retrieved from https://idiyas.com/inventor/carina-kopp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Carina Kopp - Innovator in Affinity Chromatography

Introduction

Carina Kopp is an accomplished inventor based in Peißenberg, Germany. She has made significant contributions to the field of biotechnology, particularly in the area of affinity chromatography. Although she currently holds no granted patents, her work demonstrates a commitment to advancing scientific knowledge and techniques.

Latest Patent Applications

Carina Kopp's latest patent applications include a method for the reduction of host cell proteins in affinity chromatography. This innovative approach focuses on purifying antibodies by minimizing the presence of host cell proteins. The method utilizes a wash step with a low conductivity aqueous solution during the affinity chromatography process. This application highlights her dedication to improving purification techniques in biopharmaceutical production.

Conclusion

Carina Kopp's work in affinity chromatography showcases her innovative spirit and dedication to enhancing biotechnological processes. Her contributions, although not yet reflected in granted patents, are poised to make a significant impact in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…